Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Cellular pharmacology of cyclopentenyl cytosine in Molt-4 lymphoblasts.
The toxicity, uptake, and metabolism of the oncolytic nucleoside cyclopentenyl cytosine (CPEC) have been examined in the Molt-4 line of human lymphoblasts. This compound is known to be converted to… Expand
Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by…
- C. F. Perno, R. Yarchoan, +6 authors S. Broder
- Medicine, Biology
- The Journal of experimental medicine
- 1 March 1989
We have investigated the influence of granulocyte-macrophage CSF (GM- CSF) on the replication of HIV-1 in cells of monocyte/macrophage (M/M) lineage, and its effect on the anti-HIV activity of… Expand
Metabolism and action of amino acid analog anti-cancer agents.
- G. Ahluwalia, J. Grem, Z. Hao, D. Cooney
- Biology, Medicine
- Pharmacology & therapeutics
- 1990
The preclinical pharmacology, antitumor activity and toxicity of seven of the more important amino acid analogs, with antineoplastic activity, is discussed in this review. Three of these compounds… Expand
Arabinofuranosyl-5-azacytosine: antitumor and cytotoxic properties.
- M. Dalal, J. Plowman, +6 authors D. Johns
- Biology, Medicine
- Cancer research
- 1 February 1986
Arabinofuranosyl-5-azacytosine (ara-AC), a nucleoside combining the structural elements of 5-azacytidine and arabinofuranosylcytosine, exhibited unusually wide therapeutic activity against several… Expand
Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193).
- H. Jayaram, R. Dion, +4 authors D. Cooney
- Biology, Medicine
- Biochemical pharmacology
- 15 July 1982
Studies on the mechanism of action of a new oncolytic nucleoside, 2-β-d-ribofuranosylthiazole-4-carboxamide, have been undertaken using P388 murine leukemia cells growing in culture. The title… Expand
The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
- J. Kelley, C. Litterst, +7 authors D. Johns
- Biology, Medicine
- Drug metabolism and disposition: the biological…
- 1 September 1987
The pharmacokinetics and metabolism of the anti-human T-lymphotrophic virus type III/lymphadenopathy-associated virus agent 2',3-dideoxycytidine have been examined in BDF1 mice and rhesus monkeys,… Expand
Metabolic pathways for the activation of the antiretroviral agent 2',3'-dideoxyadenosine in human lymphoid cells.
- M. A. Johnson, G. Ahluwalia, +4 authors A. Fridland
- Biology, Medicine
- The Journal of biological chemistry
- 25 October 1988
The pathways of 2',3'-dideoxyadenosine (ddAdo) metabolism, a selective inhibitor of the replication of human immunodeficiency virus, were investigated with use of the human T-lymphoid cell line… Expand
Cyclopentenylcytosine triphosphate. Formation and inhibition of CTP synthetase.
- G. Kang, D. Cooney, +4 authors D. Johns
- Chemistry, Medicine
- The Journal of biological chemistry
- 15 January 1989
Cyclopentenylcytosine (CPEC) is phosphorylated in L1210 cells with CPEC triphosphate as the major metabolite. Partially purified uridine-cytidine kinase catalyzes the initial phosphorylation of… Expand
Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid.
- T. Kensler, G. Mutter, +8 authors D. Cooney
- Biology, Medicine
- Cancer research
- 1 March 1981
Variants of the Lewis lung carcinoma were selected for resistance to N-(phosphonacetyl)-L-aspartic acid (PALA) by treatment of tumor-bearing mice with repetitive subcurative doses of PALA. The… Expand
Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
- N. Hartman, G. Ahluwalia, +5 authors D. Johns
- Biology, Medicine
- Molecular pharmacology
- 1 July 1991
2',3'-Dideoxyadenosine (ddAdo) and its deamination product 2',3'-dideoxyinosine (ddIno) (didanosine) inhibit the replication and infectivity of the human immunodeficiency virus (HIV) in a number of… Expand